Narrative review / 2021
Current evidence does not support considering fluoride a human developmental neurotoxicant at typical European exposure levels.
This commentary discusses the challenges of calculating benchmark doses (BMD) for fluoride neurotoxicity in humans based on currently available data. The authors note that findings from available studies are inconsistent and that positive studies frequently lack control for confounding variables, such as known neurotoxicants. Additionally, risk analyses must consider the totality of evidence, including animal and in vitro data alongside epidemiological studies. The authors conclude that despite remaining uncertainties, evidence does not support classifying fluoride as a developmental neurotoxicant at current European exposure levels.
- Study type
- Narrative review / commentary
- Who was studied
- Human populations (with focus on current exposure levels in European countries)
- What was measured
- Fluoride toxicity, developmental neurotoxicity, benchmark dose calculation
THE PAPER
Contribution to the ongoing discussion on fluoride toxicity.
Guth S, Hüser S, Roth A, Degen G, Diel P, Edlund K, Eisenbrand G, Engel KH, Epe B, Grune T, Heinz V, Henle T, Humpf HU, Jäger H, Joost HG, Kulling SE, Lampen A, Mally A, Marchan R, Marko D, Mühle E, Nitsche MA, Röhrdanz E, Stadler R, van Thriel C, Vieths S, Vogel RF, Wascher E, Watzl C, Nöthlings U, Hengstler JG. Arch Toxicol, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.